Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
boston blog main
boston top stories
cystic fibrosis
8
×
life sciences
national blog main
national top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
fda
clinical trials
deals
startups
abbvie
alzheimer's disease
cancer
cancer immunotherapy
gene therapy
gilead sciences
pfizer
What
bio
roundup
drug
acquisitions
ahead
biggest
buy
ceo
crispr
days
drugs
fda
moves
patients
prices
week
abbvie’s
albert
alliance
alzheimer’s
annual
aren’t
asco
assessed
attention
biofourmis
biotech
bourla
branded
bristol
bucks
build
calls
cancer
celebrate
cf
chance
changing
choices
color
Language
unset
unknown
Current search:
photo
×
" cystic fibrosis "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More